Form D · Other
GP STRATEGIES CORP
Elkridge, MD · CIK 0000070415
Offering snapshot reported Jan 8, 2010 · SEC filing
- Reported sold
- $20M Offering amount: $20M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 30, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 8, 2010 | Initial | $20,000,001 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-137592
Source: Form D, filed Jan 8, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Karl Baer | Executive |
| Kenneth L. Crawford | Executive |
| Donald R. Duquette | Executive |
| Harvey P. Eisen | Director |
| Sharon Esposito Mayer | Executive |
| Daniel M. Friedberg | Director |
| Marshall S. Geller | Director |
| Scott N. Greenberg | Director, Executive |
| Sue W. Kelly | Director |
| Richard C. Pfenniger, Jr. | Director |
| Douglas E. Sharp | Executive |
| A. Marvin Strait | Director |
| Fredric H. Strickland | Executive |
| Alan P. Tattersall | Executive |
| Gene A. Washington | Director |
Issuer details
Industry: Other (See others in industry)
Address:
6095 Marshalee Drive Suite 300
Elkridge, MD, 21075
Elkridge, MD, 21075